`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`APPLE INC.,
`Petitioner
`
`v.
`
`Masimo Corporation,
`Patent Owner.
`
`
`
`
`
`Case IPR2022-01291
`Patent No. 10,687,745
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`PETITIONER’S UNOPPOSED MOTION TO SEAL
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2022-01291
`Attorney Docket No. 50095-0045IP1
`
`
`
`
`INTRODUCTION
`Pursuant to the Protective Order (EX1035) in this proceeding and 37 C.F.R.
`
`§ 42.14, Petitioner Apple Inc. (“Apple”) submits this Motion to Seal (“Motion”)
`
`concurrent with the filing of Petitioner’s Reply to the Patent Owner’s Response
`
`(“Reply”). Through this Motion, Apple respectfully requests that certain
`
`information in the Reply and other information cited in the Reply or otherwise of
`
`record in this proceeding be sealed.
`
`As detailed further below, the documents and information that Apple moves
`
`to seal include Apple confidential business information (“CBI”) related to, among
`
`other things, development of Apple’s Watch products, including internal business
`
`practices and sensitive, proprietary technical and product development information
`
`concerning Apple’s Watch products. The CBI in this proceeding includes sealed
`
`documents and exhibits from related ITC Investigation (Certain Light-Based
`
`Physiological Measurement Devices and Components Thereof, Inv. No. 337-TA-
`
`1276 (ITC) involving U.S. Patent 10,687, 745 (“the ’745 Patent”) and other
`
`patents. The CBI in this proceeding further includes argument and testimony that
`
`references sealed documents and exhibits from ITC Inv. No. 337-TA-1276.
`
`Apple specifically moves to seal portions of the Reply and Exhibits 1036,
`
`1037, 1042, and 1059 that contain Apple CBI as described in the sections below.
`
`Public versions of the Reply and Exhibits 1036, 1037, 1042, and 1059 with
`
`
`
`1
`
`
`
`
`
`Case No. IPR2022-01291
`Attorney Docket No. 50095-0045IP1
`
`
`confidential portions redacted are being filed with the Reply and this Motion. The
`
`parties have conferred by email and Masimo has explained its position on the
`
`Motion as follows:
`
`“Masimo will not oppose the motion to seal Apple CBI
`that Apple produced from the ITC proceeding in response
`to Masimo’s motion for additional discovery in these IPR
`or in EX1036 or EX1037. However, to the extent Apple
`seeks to introduce Apple CBI that was not produced in
`response to Masimo’s motion for additional discovery in
`these IPRs or in EX1036 or EX1037, Masimo reserves all
`rights to oppose. Masimo also reserves the right to object
`to Apple’s Reply arguments or to any exhibits that Apple
`may submit with its Reply.”
`
`Because Apple has not introduced any new Apple CBI that was not
`
`produced responsive to the Board’s order granting-in-part Masimo’s motion for
`
`additional discovery or that is not in Exhibits 1036 or 1037, Apple understands that
`
`this Motion is unopposed.
`
` THE DOCUMENTS REQUESTED TO BE SEALED CONTAIN
`CONFIDENTIAL BUSINESS INFORMATION
`In an inter partes review (“IPR”), the Board will grant a motion to seal upon
`
`a showing of “good cause” for the relief requested. 37 C.F.R. § 42.20(c). The Board
`
`has explained that “a movant to seal must demonstrate adequately that (1) the
`
`
`
`2
`
`
`
`Case No. IPR2022-01291
`Attorney Docket No. 50095-0045IP1
`
`information sought to be sealed is truly confidential, (2) a concrete harm would result
`
`
`
`upon public disclosure, (3) there exists a genuine need to rely in the trial on the
`
`specific information sought to be sealed, and (4), on balance, an interest in
`
`maintaining confidentiality outweighs the strong public interest in having an open
`
`record.” Argentum Pharmaceuticals LLC v. Alcon Research, Ltd., IPR2017-01053,
`
`Paper 27 at 4 (PTAB Jan. 19, 2018) (informative).
`
`Apple respectfully submits that each of the Argentum conditions is satisfied
`
`and that good cause exists for the relief requested in this Motion.
`
`
`
`Identification of Documents and Information that Apple
`Moves to Seal
`
`Apple moves to seal the following information:
`
`First, Apple moves to seal identified portions of the Supplemental Declaration
`
`of Dr. Brian Anthony (APPLE-1042). These portions of Dr. Anthony’s
`
`Supplemental Declaration reference testimony from witnesses offered in closed
`
`session in ITC Inv. No. 337-TA-1276. These portions of Dr. Anthony’s
`
`Supplemental Declaration further reference various confidential exhibits from ITC
`
`Inv. No. 337-TA-1276 that have been entered in this proceeding. The identified
`
`information from these portions of Dr. Anthony’s Supplemental Declaration
`
`includes quotes, images, and discussion of CBI related to Apple’s Watch products,
`
`including sensitive, proprietary research and development (R&D) information, trade
`
`
`
`3
`
`
`
`Case No. IPR2022-01291
`Attorney Docket No. 50095-0045IP1
`
`secrets, proprietary processes and apparatuses, and confidential business operations
`
`
`
`information.
`
`Second, Apple moves to seal identified portions of the deposition transcript
`
`of R. James Duckworth, Ph.D., conducted August 9, 2023 (APPLE-1059). These
`
`portions of Dr. Duckworth’s deposition transcript include questions and testimony
`
`that refer to various confidential exhibits that have been entered in the subject IPR
`
`from ITC Inv. No. 337-TA-1276. The questioning and testimony in the identified
`
`portions of the transcript include discussion of CBI related to Apple’s Watch
`
`products, including sensitive, proprietary research and development (R&D)
`
`information, trade secrets, proprietary processes and apparatuses, and confidential
`
`business operations information.
`
`Third, Apple moves to seal pages 5-23 of the transcript of Dr. Ueyn Block’s
`
`testimony from a hearing in ITC Inv. No. 337-TA-1276 (APPLE-1036). These
`
`pages of the hearing transcript were conducted in closed session at the ITC and
`
`include questioning and testimony related to Apple’s Watch products, including
`
`sensitive, proprietary research and development (R&D) information, trade secrets,
`
`proprietary processes and apparatuses, and confidential business operations
`
`information.
`
`Fourth, Apple moves to seal pages 3-21 of the transcript of Dr. Saahil Mehra’s
`
`testimony from a hearing in ITC Inv. No. 337-TA-1276 (APPLE-1037). These
`
`
`
`4
`
`
`
`Case No. IPR2022-01291
`Attorney Docket No. 50095-0045IP1
`
`pages of the hearing transcript were conducted in closed session at the ITC and
`
`
`
`include questioning and testimony related to Apple’s Watch products, including
`
`sensitive, proprietary research and development (R&D) information, trade secrets,
`
`proprietary processes and apparatuses, and confidential business operations
`
`information.
`
`Fifth, Apple moves to seal identified portions of Petitioner’s Reply to Patent
`
`Owner’s Response in this proceeding. These portions of the Reply reference and
`
`discuss Apple CBI from ITC Inv. No. 337-TA-1276, and include discussion of CBI
`
`related to Apple’s Watch products, including sensitive, proprietary research and
`
`development (R&D) information, trade secrets, proprietary processes and
`
`apparatuses, and confidential business operations information.
`
` The Information Sought to be Sealed is Truly Confidential
`
`The Reply and Exhibits 1036, 1037, 1042, and 1059 each contain truly
`
`confidential information that falls within the scope of Confidential Information
`
`agreed to by the parties and approved by the Board in the Protective Order in this
`
`proceeding. See APPLE-1035. The confidential information includes information
`
`from closed session hearings at the ITC, information that has already been sealed
`
`at the ITC, and analysis and discussion of such information. The information
`
`includes sensitive, proprietary research and development (R&D) information, trade
`
`secrets, proprietary processes and apparatuses, and confidential business operations
`
`
`
`5
`
`
`
`
`
`information belonging to Apple.
`
`Case No. IPR2022-01291
`Attorney Docket No. 50095-0045IP1
`
`
` Apple Would Suffer Concrete Harm Upon Public Disclosure
`of the Information Sought to be Sealed
`
`The CBI contained in the Reply and Exhibits 1036, 1037, 1042, and 1059
`
`includes sensitive, proprietary research and development (R&D) information
`
`related to Apple’s Watch products, trade secrets, proprietary processes and
`
`apparatuses, and confidential business operations. The information includes
`
`testimony from engineers, and internal documents related to the design and
`
`development of aspects of the Watch. The testimony and internal documents
`
`contain sensitive and proprietary information regarding technical development of
`
`the Watch and proprietary processes and information relating to the same. Among
`
`other things, Apple would suffer concrete financial harm through exposure of
`
`proprietary, trade secret information to competitors who could leverage Apple’s
`
`substantial investment in research and development of the Watch to their own
`
`advantage. The parties have agreed that disclosure of such CBI would “likely have
`
`the effect of … causing substantial harm to the competitive position of the person,
`
`firm, partnership, corporation, or other organization from which the information
`
`was obtained.” EX1035 at 1
`
` Apple’s Interest in Maintaining Confidentiality Outweighs
`the Strong Public Interest in Having an Open Record
`
`On balance, Apple’s interest in maintaining confidentiality outweighs the
`
`
`
`6
`
`
`
`
`
`Case No. IPR2022-01291
`Attorney Docket No. 50095-0045IP1
`
`
`strong public interest in having an open record. See Argentum at 3-4. As noted
`
`above, the CBI that Apple moves to seal is truly confidential and Apple would
`
`suffer concrete harm if the information were made available to the public.
`
`Moreover, Apple is not seeking to seal the exhibits in their entirety but
`
`moves to seal those aspects of the exhibits and the reply that are truly confidential
`
`and would likely cause harm to Apple if publicly disclosed. Apple is concurrently
`
`filing redacted versions of the Reply and Exhibits. The public will have full access
`
`to the nature of the information and the conclusions reached using the information
`
`as portions of Apple’s Reply remains unsealed. Such access should adequately
`
`fulfill the public’s need to maintain a complete file history, while still protecting
`
`Apple’s confidential and proprietary information.
`
`Finally, Apple also notes that the CBI that requested to be sealed primarily
`
`involves information that Apple was compelled to produce to Masimo pursuant to
`
`the Board’s order granting Masimo’s motion for additional discovery, along with a
`
`pair of exhibits (i.e., APPLE-1036, APPLE-1037) that Apple entered as
`
`supplemental information in response to Masimo’s discovery motion. Apple’s CBI
`
`should not risk being exposed to the public on account of Masimo’s discovery.
`
` CONCLUSION
`For these reasons, Apple respectfully requests that the Board seal and protect
`
`the Reply and confidential Exhibits 1036, 1037, 1042, and 1059. Apple further
`
`
`
`7
`
`
`
`Case No. IPR2022-01291
`Attorney Docket No. 50095-0045IP1
`
`respectfully requests that the Board seal and protect the confidential information in
`
`
`
`
`
`
`
`these exhibits until such time as it receives and rules on this Motion.
`
`
`Dated: August 21, 2023
`
`
`
`
`
`
`
`
`
`
`
`
`(Control No. IPR2022-01291)
`
`
`
`
`
`
`
`/Nicholas W. Stephens/
` W. Karl Renner, Reg. No. 41,265
` Nicholas Stephens, Reg. No. 74,320
` Andrew B. Patrick, Reg. No. 63,471
` Kim Leung, Reg. No. 64,399
` Patrick J. Bisenius, Reg. No. 63,893
` Patrick J. King, Reg. No. 60,816
` Fish & Richardson P.C.
`
`60 South Sixth Street
` Minneapolis, MN 55402
` T: 202-783-5070
` F: 877-769-7945
`
`
`
`Attorneys for Petitioner
`
`
`
`8
`
`
`
`
`
`Case No. IPR2022-01291
`Attorney Docket No. 50095-0045IP1
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR §§ 42.6(e)(1) and 42.6(e)(4)(iii), the undersigned
`
`certifies that on August 21, 2023, a complete and entire copy of this Petitioner’s
`
`Unopposed Motion to Seal was provided via email to the Patent Owner by serving
`
`the email correspondence addresses of record as follows:
`
`Brian C. Claassen (Reg. No. 63,051)
`Carol Pitzel Cruz (Reg. No. 61,224)
`Daniel C. Kiang (Reg. No. 79,631)
`Jeremiah S. Helm (Pro Hac Vice)
`
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`2040 Main Street, Fourteenth Floor
`Irvine, CA 92614
`Tel.: (949) 760-0404
`Fax: (949) 760-9502
`
`E-mail: AppleIPR745-1@knobbe.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/Crena Pacheco/
`Crena Pacheco
`Fish & Richardson P.C.
`60 South Sixth Street
`Minneapolis, MN 55402
`pacheco@fr.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`9
`
`